NCT06651034View on ClinicalTrials.gov

Efficacy of Intralesional Platelet Rich Plasma in Patients of De Quervain's Tenosynovitis

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

October 30, 2022

Study Completion Date

October 30, 2022

Conditions
De Quervain Tenosynovitis
Interventions
OTHER

Platelet Rich Plasma

Under aseptic measures, a phlebotomist obtained the blood in vacutainers. Vacutainers was centrifuged and middle zone containing platelet rich plasma was aspirated in a 5 ml disposable syringe. The patient received intralesional injection

Trial Locations (1)

Unknown

Department of Orthopedic surgery, KEMU/ Affiliated hospital, Lahore

All Listed Sponsors
lead

Muhammad Aamir Latif

OTHER

NCT06651034 - Efficacy of Intralesional Platelet Rich Plasma in Patients of De Quervain's Tenosynovitis | Biotech Hunter | Biotech Hunter